Authors:
Mishima, K
Johns, TG
Luwor, RB
Scott, AM
Stockert, E
Jungbluth, AA
Ji, XD
Suvarna, P
Voland, JR
Old, LJ
Huang, HJS
Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001), CANCER RES, 61(20), 2001, pp. 7703-7703
Authors:
Mishima, K
Johns, TG
Luwor, RB
Scott, AM
Stockert, E
Jungbluth, AA
Ji, XD
Suvarna, P
Voland, JR
Old, LJ
Huang, HJS
Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, CANCER RES, 61(14), 2001, pp. 5349-5354
Authors:
Luwor, RB
Johns, TG
Murone, C
Huang, HJS
Cavenee, WK
Ritter, G
Old, LJ
Burgess, AW
Scott, AM
Citation: Rb. Luwor et al., Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR, CANCER RES, 61(14), 2001, pp. 5355-5361